Target intelligence / Profile preview

D-Alanyl-D-alanine terminus of bacterial peptidoglycan precursor (None commonly used.)

Target
None commonly used.
Molecular classification
Other (motif/terminus rather than a protein, receptor, or enzyme), Peptidoglycan precursor motif
01

Overview

The D-Ala-D-Ala terminus is a short dipeptide at the end of peptidoglycan precursor pentapeptides in most bacterial species, especially Gram-positive. This motif is generated in the cytoplasm by D-Ala-D-Ala ligase and incorporated in lipid II, which is then used for cell wall assembly by transglycosylases and transpeptidases. Vancomycin and related glycopeptides specifically recognize and bind this motif by hydrogen bonding, blocking cell wall cross-linking and resulting in bacterial death. Many bacteria have evolved resistance mechanisms by substituting D-Ala-D-Ala with D-Ala-D-Lac or D-Ala-D-Ser, greatly reducing glycopeptide binding. As a non-protein, non-enzyme motif, the D-Ala-D-Ala terminus is best classified as a chemical target structure involved in bacterial cell wall assembly, not a classical receptor or enzyme. Its direct involvement in antibiotic resistance makes it an important target in infectious diseases, especially the treatment of multidrug-resistant organisms.

Other names
D-Ala-D-AlaD-Alanyl-D-alanine terminusPeptidoglycan D-Ala-D-AlaLipid II D-Ala-D-AlaPeptidoglycan precursor pentapeptide terminus
02

Mechanism of action

Glycopeptides (vancomycin, teicoplanin) bind to the D-Ala-D-Ala terminus, inhibiting transpeptidation and transglycosylation by physically blocking enzymes responsible for cross-linking peptidoglycan chains, thus preventing bacterial cell wall formation and causing cell death. D-cycloserine inhibits D-Ala-D-Ala ligase needed for terminus formation.

03

Biological functions

Cell wall biosynthesisBacterial cell shape maintenanceBacterial cell divisionAntibiotic binding (target for vancomycin and similar drugs)Immune modulation (through structural variability of terminus)
04

Disease associations

Infection (central role in bacterial cell viability and pathogenicity)Antibiotic resistance (modification of this terminus is a key mechanism in vancomycin resistance)
05

Safety considerations

Non-specific toxicity: most relevant for drugs targeting this motif, especially nephrotoxicity and ototoxicity for vancomycin and similar glycopeptides.Resistance development: modification of motif (D-Ala-D-Lac or D-Ala-D-Ser) in bacteria leads to reduced drug efficacy.
06

Interacting drugs

Vancomycin

4 more in the full profile.

07

Biomarkers

Presence of D-Ala-D-Ala in peptidoglycan precursor (detected by biochemical assays or vancomycin susceptibility)Altered precursor (D-Ala-D-Lac or D-Ala-D-Ser), associated with vancomycin-resistant organisms

Beyond the preview

Go deeper on D-Alanyl-D-alanine terminus of bacterial peptidoglycan precursor (None commonly used.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-Alanyl-D-alanine terminus of bacterial peptidoglycan precursor (None commonly used.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call